AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie janssen Biotech Collaboration (Imbruvica) — International Profit Share in Net Revenues ($M) ($M)
Form 10-Q / 10-K Licensing, Acquisitions & Other Arrangements Note
Latest, FY2025
821
Period ended Dec 31, 2025
Change on a year earlier
-8.7%
899 in FY2024
History
8 years
Since FY2018
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Janssen Biotech Collaboration (Imbruvica) — International Profit Share in Net Revenues ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 821 | -8.7% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 899 | -3.4% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 931 | -18.5% | Form 10-K (filed 2026-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 1,142 | +5.1% | Form 10-K (filed 2025-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 1,087 | +7.7% | Form 10-K (filed 2024-02-20) ↗ |
| FY2020 | Dec 31, 2020 | 1,009 | +19.5% | Form 10-K (filed 2023-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 844 | +35.7% | Form 10-K (filed 2022-02-18) ↗ |
| FY2018 | Dec 31, 2018 | 622 | – | Form 10-K (filed 2021-02-19) ↗ |
Breakdown
What makes up janssen biotech collaboration (imbruvica) — international profit share in net revenues ($m)
- Janssen U.S. Profit Share Recorded in AbbVie Cost of Products Sold ($M)954 · FY2025
- AbbVie Share of Janssen Other Collaboration Costs [annual] ($M)101 · FY2025
- Payable to Janssen Biotech [year-end] ($M)189 · FY2025
- Receivable from Janssen Biotech [year-end] ($M)218 · FY2025
- Milestone & Profit Share Receivable from Janssen [year-end] ($M)200 · FY2025
Cite this data
StockData. (2026). AbbVie Janssen Biotech Collaboration (Imbruvica) — International Profit Share in Net Revenues ($M) ($M), annual FY2018–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/collab_janssen_rev
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.